PRKDC and small cell lung carcinoma: Their findings demonstrate that blockage of DNA-PK or disruption of the interaction between OCT4 and DNA-PK provokes a reduction in c-MYC expression and exerts anticancer effects in both SCLC cell lines and xenograft models.224